Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

143.52
-1.1711-0.81%
Volume:27.69K
Turnover:3.97M
Market Cap:200.93M
PE:- -
High:144.92
Open:144.92
Low:142.14
Close:144.69
52wk High:150.00
52wk Low:74.34
Shares:1.40M
Float Shares:1.40M
Volume Ratio:0.98
T/O Rate:1.98%
Dividend:1.26
Dividend Rate:0.88%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14

'It's a Double-Edged Sword': My Husband Got a $42,000 Bonus. Will it Wipe Out Our Affordable Care Act Subsidy?

Dow Jones
·
Aug 14

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Sands Capital boosts Eli Lilly stake with 12,445 shares

TIPRANKS
·
Aug 14

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Dow Jones
·
Aug 14

Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million

Reuters
·
Aug 14

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Berenberg Adjusts Price Target on Eli Lilly to $1,220 From $1,135, Maintains Hold Rating

MT Newswires Live
·
Aug 13

Eli Lilly : Berenberg Raises Target Price to $1220 from $1135

THOMSON REUTERS
·
Aug 13

Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly

TIPRANKS
·
Aug 13

Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 12

Eli Lilly (LLY) Sues Six Companies Over Weight-Loss Drug Sales

TIPRANKS
·
Aug 12

Eli Lilly is Suing Pharmacies and Peptide Vendors over Sales of the Next Big Weight-Loss Drug: Retatrutide

Dow Jones
·
Aug 12

Amplifica Holdings Group: Closes Oversubscribed $26 Mln Series B Preferred Stock Financing Led by Tasso Partners, Participation from Eli Lilly & Co

THOMSON REUTERS
·
Aug 12